Industry News

Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
American Academy of Dermatology Association Applauds Congress for Passing Sunscreen Innovation Act
PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub
Acology in Discussions With Altura Pharmaceutical for 8 State Distribution Agreement for the Medtainer
Acology in Discussions With Altura Pharmaceutical for 8 State Distribution Agreement for the Medtainer
PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub And Distribution Centre State-of-the-art facility in Berlin-Schönefeld, Germany delivers end-to-end supply chain management and distribution ser
Ireland : PERRIGO buys OMEGA PHARMA
AcelRx Pharmaceuticals Receives International Standards Organization Certification Of Its Quality Management System
Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters
Drug Makers Report an Average 22% of Patient-Reported Outcomes Endpoints Appear on Final Product Labels Though Pharmaceutical Companies Implement High Quality Measures to Capture the Patient Experience, Internal and External Factors Influence Regulators
Ireland : PERRIGO buys OMEGA PHARMA
Teva Presents Positive Safety and Efficacy Data for QNASL (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children with Perennial Allergic Rhinitis
Endo Receives Final Approval for Generic Version of Valcyte
Actamax Announces Positive Results from First Clinical Trial Demonstrating Safety, Ease of use and Efficacy of Novel Sprayable Adhesion Barrier Device
Actamax Announces Positive Results from First Clinical Trial Demonstrating Safety, Ease of use and Efficacy of Novel Sprayable Adhesion Barrier Device
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Endo Receives Final Approval for Generic Version of Valcyte�
Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis
Eagle Pharmaceuticals Reports Positive Outcomes From Clinical Trial Of Bendamustine HCl Product Delivered Via Low-Volume, Rapidly Infused Admixture
FDA Grants QIDP Fast-Track Designation to RedHill Biopharma's Phase III H. pylori Drug RHB-105
CytoSorbents Announces Initial Partnership with a Leading Global Cardiac Surgery Company
Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis
Pharco Pharmaceuticals Licenses Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 from Presidio Pharmaceuticals
AcelRx Pharmaceuticals Receives International Standards Organization Certification Of Its Quality Management System
Dendreon files for Ch. 11 bankruptcy protection